Impact of Nutritional Management on the Frailty of Patients Waiting for Liver Transplantation (Via the LFI Tool)
Launched by HOSPICES CIVILS DE LYON · Mar 28, 2025
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how nutritional support can affect the health of patients who are waiting for a liver transplant. Many patients with severe liver disease, known as cirrhosis, can become weak and malnourished while they wait for a transplant. The study will use a special tool called the Liver Frailty Index (LFI) to assess how fragile these patients are. The researchers want to see if regular follow-ups with a dietitian, who is an expert in nutrition for liver patients, can help improve their strength and overall health compared to standard care without specific dietary guidance.
To participate in the study, patients must be at least 18 years old, currently on the liver transplant waiting list, and able to perform some simple exercises to measure their strength. The trial will include around 210 patients over two years, and all participants will have their frailty levels checked at three and six months. This study aims to find out if better nutrition can make a difference in how patients feel and their chances of getting a transplant, helping doctors understand the best ways to support patients during this critical time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient aged ≥ 18 years
- • Patient registered on the waiting list for Hepatic Transplantation in the Transplantation center of the Croix Rousse Hospital (GHN), Hospices Civils de Lyon
- • Dated and signed an informed consent
- • Affiliated to a social security scheme or beneficiary of a similar scheme
- Exclusion Criteria:
- • Patient hospitalized in intensive care
- • Patient with initial LFI test result \< to 3.2, that is considered as "robust".
- • Patient unable to perform LFI exercises (chronic or acute motor disability in lower or upper limbs)
- • Pregnant, parturient or lactating women
- • Persons deprived of liberty by a judicial or administrative decision
- • Persons under psychiatric care
- • Persons admitted to a health or social institution for purposes other than research
- • Adults subject to a legal protection measure (guardianship, curatorship)
- • Inability to understand protocol information
- • Subject participating in another interventional research including an ongoing exclusion period at inclusion
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lyon, , France
Patients applied
Trial Officials
Maxime PATUREL
Principal Investigator
Service Rééducation Nutritionnelle Hôpital de la Croix Rousse / GHN
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported